Aptose Biosciences Inc.·4

Sep 25, 5:03 PM ET

Seizinger Bernd R. 4

4 · Aptose Biosciences Inc. · Filed Sep 25, 2023

Insider Transaction Report

Form 4
Period: 2023-09-22
Transactions
  • Purchase

    Common Shares

    2023-09-22$3.14/sh+17,000$53,38017,000 total
Footnotes (1)
  • [F1]The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.13 to $3.14, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc.., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Documents

2 files
  • 4
    form4.xmlPrimary
  • EX-24.2

    POWER OF ATTORNEY